November 24, 2022 Comments Off on New patent for Allergan Holdings drug VIBERZI Posted in: Patent Added Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Allergan Holdings drug VIBERZI appeared first …
November 24, 2022 Comments Off on New patent for Beigene drug BRUKINSA Posted in: Patent Added Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. There are four patents protecting this drug. This drug has forty-four…
The post New patent for Beigene drug BRUKINSA appeared first on DrugPa…
